Cugene Inc.
PrivateLast Round
Growth Equity
May 1, 2024
Total Funding Raised
$48.5M
Company Overview
Cugene Inc. is a biotechnology company developing next-generation medicines for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cugene Inc. Comps
Public and private peers based on sector, stage, and business model.
Cugene Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 1, 2024 | ||||
| Corporate Funding | May 16, 2022 |
Cugene Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Summer Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors grew 307% MoM, reaching 1.9K.
- May 3, 2025
Monthly visitors grew 363% MoM, from 389 to 1.8K.
Cugene Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cugene Inc.'s valuation, stock price, and market status.
